Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies Advances in Cancer Research Series

Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies, Volume 161 in the Advances in Cancer Research series, covers timely topics such as The Prostate Cancer Tissue N-glycome as a Source of Biomarkers, a Progression from Normal to Metastatic Disease, Multiplexed Targeted Proteomics for Prostate Cancer Biomarker Verification, MRI for the Detection of Clinically Significant Prostate Cancer: Update and Future Directions, Genetic and epigenetic factors for prostate cancer progression, Epigenetic regulation of androgen dependent and independent prostate cancer, Molecular Landscape of Prostate Cancer Bone Metastasis, Future of radioligand Therapy in PC, and more.

Additional chapters of note include Advancements in Computer Vision and Pathology: Unraveling the Potential of Artificial Intelligence for Precision Diagnosis and Beyond and Extracellular Vesicles in Prostate Cancer.

1. The Prostate Cancer Tissue N-glycome as a Source of Biomarkers, a Progression from Normal to Metastatic Disease
2. Multiplexed Targeted Proteomics for Prostate Cancer Biomarker Verification
3. MRI for the Detection of Clinically Significant Prostate Cancer: Update and Future Directions
4. Genetic and epigenetic factors for prostate cancer progression
5. Epigenetic regulation of androgen dependent and independent prostate cancer
6. Molecular Landscape of Prostate Cancer Bone Metastasis
7. Future of radioligand Therapy in PC
8. Advancements in Computer Vision and Pathology: Unraveling the Potential of Artificial Intelligence for Precision Diagnosis and Beyond
9. Extracellular Vesicles in Prostate Cancer